Messages That Motivate: Communicating Alcohol-Related Breast Cancer Risk to Young Adult Women

Part of paid clinical trials in Columbus, Ohio.

Sponsor
Ohio State University Comprehensive Cancer Center
Study ID
NCT07802054
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Alcohol
  • Behavior, Risk
  • Cancer Prevention
  • Communication
  • Message Perception

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 25 Years
Healthy Volunteers
Accepted

Interventions

  • Risk Message — BEHAVIORAL
    Risk message content
  • Efficacy Message — BEHAVIORAL
    Efficacy Message Content
  • Industry Deception — BEHAVIORAL
    Messages with information about alcohol industry deception
  • YAW Susceptibility — BEHAVIORAL
    Message content with information about why young adult women are susceptible to breast cancer risk from alcohol consumption
  • Mechanisms — BEHAVIORAL
    Message content with information about the mechanism by which alcohol contributes to increased breast cancer risk

Study Details

This is an online cross-sectional experimental survey study examining two cancer communication questions: 1) What features of social media messages communicating the breast cancer risks from alcohol consumption will motivate young adult women to drink less? and 2) Do message features differ in their persuasive effects based on young adult women's alcohol consumption behavior?

Key Dates

First listed
Sep 3, 2026
Start date
Oct 31, 2026
Status verified
Sep 2026
Primary completion
Jun 30, 2028
Completion
Jul 31, 2028

Study Design

Enrollment
900 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Arm 1: Risk Only + Industry Deception
  • Experimental: Arm 2: Risk Only + YAW Susceptibility
  • Experimental: Arm 3: Risk Only + Mechanisms
  • Experimental: Arm 4: Efficacy Only + Industry Deception
  • Experimental: Arm 5: Efficacy Only + YAW Susceptibility
  • Experimental: Arm 6: Efficacy Only + Mechanisms
  • Experimental: Arm 7: Risk and Efficacy + Industry Deception
  • Experimental: Arm 8: Risk and Efficacy + YAW Susceptibility
  • Experimental: Arm 9: Risk and Efficacy + Mechanisms

Primary Outcome Measure

Message Perceptions [ Time Frame: This assessment is administered immediately after participants view study messages on Day 1 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The Ohio State University Comprehensive Cancer CenterColumbusOhio43210
Darren Mays, MPH, PhD
614-366-2953
Darren Mays, MPH, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Columbus, OH

Related Studies